Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Classement en actions #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Prix de l'action
$70.50
Dernière synchronisation: 2025-11-14
Capitalisation boursière
$7.33B
Changement (1 jour)
0.00%
Changement (1 an)
116.32%
Pays
US
Échange Metsera, Inc. (MTSR)

Catégorie

Historique du prix de l'action pour Metsera, Inc. (MTSR)
Prix de clôture le plus élevé : $72.34 le 2025-11-01

Prix de clôture le plus bas : $26.50 le 2025-01-01
Historique du prix de l'action de Metsera, Inc. de 2025 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -29.98%
2025 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH